BioNTech stock plunges as founders leave. Should you buy the dip in BNTX here?
BioNTech (BNTX) stock is down nearly 20% at the time of writing after the German company posted a Q4 loss, issued muted guidance, and said its cofounders will depart by the end of this year CEO Uğur Şahin and Chief Medical Officer Özlem Türeci, who...
Barchart